199 related articles for article (PubMed ID: 9165209)
41. Recognizing the Toxicodendrons (poison ivy, poison oak, and poison sumac).
Guin JD; Gillis WT; Beaman JH
J Am Acad Dermatol; 1981 Jan; 4(1):99-114. PubMed ID: 6451640
[TBL] [Abstract][Full Text] [Related]
42. A study of cross-reactions between mango contact allergens and urushiol.
Oka K; Saito F; Yasuhara T; Sugimoto A
Contact Dermatitis; 2004; 51(5-6):292-6. PubMed ID: 15606656
[TBL] [Abstract][Full Text] [Related]
43. A murine model system for contact sensitization to poison oak or ivy urushiol components.
Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
[No Abstract] [Full Text] [Related]
44. Topical prevention of poison ivy/oak dermatitis.
Epstein WL
Arch Dermatol; 1989 Apr; 125(4):499-501. PubMed ID: 2522756
[TBL] [Abstract][Full Text] [Related]
45. Black-spot poison ivy dermatitis. An acute irritant contact dermatitis superimposed upon an allergic contact dermatitis.
Hurwitz RM; Rivera HP; Guin JD
Am J Dermatopathol; 1984 Aug; 6(4):319-22. PubMed ID: 6238544
[TBL] [Abstract][Full Text] [Related]
46. The effect of oral ibuprofen on patch test reactivity in subjects allergic to poison ivy/oak.
Sherertz EF
J Am Acad Dermatol; 1997 Apr; 36(4):647-9. PubMed ID: 9092762
[No Abstract] [Full Text] [Related]
47. COMPARISON OF THE POTENCY OF POISON IVY EXTRACTS WITH SYNTHETIC PENTADECYLCATECHOL IN SENSITIVE HUMANS.
AUERBACH R; BAER H
J Allergy; 1964; 35():201-5. PubMed ID: 14160428
[No Abstract] [Full Text] [Related]
48. Black-spot poison ivy.
Schram SE; Willey A; Lee PK; Bohjanen KA; Warshaw EM
Dermatitis; 2008; 19(1):48-51. PubMed ID: 18346397
[TBL] [Abstract][Full Text] [Related]
49. Toxicodendron succedaneum (Rhus tree), New Zealand's poison ivy.
Rademaker M; Duffill MB
Contact Dermatitis; 1995 Nov; 33(5):357-8. PubMed ID: 8565502
[No Abstract] [Full Text] [Related]
50. Treatment of toxicodendron dermatitis (poison ivy and poison oak).
Guin JD
Skin Therapy Lett; 2001 Apr; 6(7):3-5. PubMed ID: 11376396
[TBL] [Abstract][Full Text] [Related]
51. Black spot poison ivy.
McClanahan C; Asarch A; Swick BL
Int J Dermatol; 2014 Jun; 53(6):752-3. PubMed ID: 24601999
[No Abstract] [Full Text] [Related]
52. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
Dupuis G
Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
[TBL] [Abstract][Full Text] [Related]
53. Myths & facts ... about poison ivy.
Nursing; 1998 Apr; 28(4):17. PubMed ID: 9601373
[No Abstract] [Full Text] [Related]
54. Basophil degranulation induced by oral poison ivy antigen.
Shelley WB; Resnik SS
Arch Dermatol; 1965 Aug; 92(2):147-50. PubMed ID: 11850914
[TBL] [Abstract][Full Text] [Related]
55. Contact dermatitis to Rhus succedanea.
Nakamura T
Contact Dermatitis; 1985 May; 12(5):279. PubMed ID: 3161688
[No Abstract] [Full Text] [Related]
56. Toxicodendron hyposensitization programs.
Watson ES
Clin Dermatol; 1986; 4(2):160-70. PubMed ID: 2941127
[No Abstract] [Full Text] [Related]
57. The poison ivy picker of Pennypack Park: the continuing saga of poison ivy.
Epstein WL
J Invest Dermatol; 1987 Mar; 88(3 Suppl):7s-11s. PubMed ID: 2950182
[No Abstract] [Full Text] [Related]
58. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
[TBL] [Abstract][Full Text] [Related]
59. Induction of antigen specific hyposensitization to poison oak in sensitized adults.
Epstein WL; Byers VS; Frankart W
Arch Dermatol; 1982 Sep; 118(9):630-3. PubMed ID: 6180687
[TBL] [Abstract][Full Text] [Related]
60. Urushiol detection using a profluorescent nitroxide.
Braslau R; Rivera F; Lilie E; Cottman M
J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
